These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31236817)

  • 41. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Vitro and In Vivo Evaluation of Casein as a Drug Carrier for Enzymatically Triggered Dissolution Enhancement from Solid Dispersions.
    Bani-Jaber A; Alshawabkeh I; Abdullah S; Hamdan I; Ardakani A; Habash M
    AAPS PharmSciTech; 2017 Jul; 18(5):1750-1759. PubMed ID: 27752935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.
    Papadimitriou S; Bikiaris D
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1128-38. PubMed ID: 19555245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate.
    Jadhav NV; Vavia PR
    AAPS PharmSciTech; 2017 Oct; 18(7):2764-2773. PubMed ID: 28353172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers.
    Ng CL; Lee SE; Lee JK; Kim TH; Jang WS; Choi JS; Kim YH; Kim JK; Park JS
    Int J Pharm; 2016 Oct; 512(1):314-321. PubMed ID: 27593897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro evaluation and in vivo performance of lyophilized gliclazide.
    Mansour HF; Aly UF
    Drug Dev Ind Pharm; 2015 Apr; 41(4):650-7. PubMed ID: 24568609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.
    Suhagia BN; Patel HM; Shah SA; Rathod I; Parmar VK
    Acta Pharm; 2006 Sep; 56(3):285-98. PubMed ID: 19831278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic evaluation of dual functionality of sodium lauryl sulfate as a tablet lubricant and wetting enhancer.
    Dun J; Osei-Yeboah F; Boulas P; Lin Y; Sun CC
    Int J Pharm; 2018 Dec; 552(1-2):139-147. PubMed ID: 30261213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of PVP/PEG mixtures as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique and optimization of dissolution using artificial neural networks.
    Barmpalexis P; Koutsidis I; Karavas E; Louka D; Papadimitriou SA; Bikiaris DN
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1219-31. PubMed ID: 23541514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
    Al-Obaidi H; Lawrence MJ; Buckton G
    J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.
    Hasegawa S; Furuyama N; Yada S; Hamaura T; Kusai A; Yonemochi E; Terada K
    Int J Pharm; 2007 May; 336(1):82-9. PubMed ID: 17178201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
    Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions.
    Yang C; Xu X; Wang J; An Z
    Chem Pharm Bull (Tokyo); 2012; 60(7):837-45. PubMed ID: 22790815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fabrication and characterization of chitosan, polyvinylpyrrolidone, and cellulose nanowhiskers nanocomposite films for wound healing drug delivery application.
    Hasan A; Waibhaw G; Tiwari S; Dharmalingam K; Shukla I; Pandey LM
    J Biomed Mater Res A; 2017 Sep; 105(9):2391-2404. PubMed ID: 28445626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I.
    Papadimitriou SA; Barmpalexis P; Karavas E; Bikiaris DN
    Eur J Pharm Biopharm; 2012 Sep; 82(1):175-86. PubMed ID: 22732266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.